Immediate Impact
76 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
2024 Standout
Works of Niklas Beyhoff being referenced
Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Niklas Beyhoff | 139 | 27 | 71 | 166 | 95 | 22 | 327 | |
| Shaoli Chu | 150 | 13 | 90 | 96 | 76 | 22 | 315 | |
| Konstantinos Markakis | 112 | 32 | 47 | 103 | 130 | 14 | 334 | |
| G. E. Wakerlin | 116 | 36 | 58 | 61 | 55 | 24 | 337 | |
| Imma Forzano | 85 | 10 | 59 | 119 | 60 | 16 | 254 | |
| M Takahashi | 156 | 45 | 97 | 110 | 38 | 18 | 366 | |
| Jillian N. Noblet | 149 | 15 | 81 | 74 | 77 | 27 | 297 | |
| Janek Salatzki | 112 | 61 | 56 | 66 | 82 | 32 | 316 | |
| H. P. Gurtner | 117 | 33 | 122 | 127 | 70 | 22 | 352 | |
| Jong Ho Kim | 84 | 15 | 52 | 142 | 75 | 19 | 345 | |
| Tsutomu Ryoke | 252 | 41 | 60 | 75 | 115 | 14 | 365 |
All Works
Login with ORCID to disown or claim papers
Loading papers...